{
    "2018-11-23": [
        [
            {
                "time": "2018-11-26",
                "original_text": "Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 26, 2018",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Ex-Dividend",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod",
                "features": {
                    "keywords": [
                        "Boeing",
                        "Supply",
                        "Pfizer",
                        "FDA Nod"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "aerospace",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",
                "features": {
                    "keywords": [
                        "Cancer Approvals",
                        "PFE",
                        "ABBV",
                        "CHMP Nod"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Bayer Hurts from Generic Competition & Pipeline Setbacks",
                "features": {
                    "keywords": [
                        "Bayer",
                        "Generic Competition",
                        "Pipeline Setbacks"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Gauging Analysts’ Views on Tesaro Stock",
                "features": {
                    "keywords": [
                        "Analysts’ Views",
                        "Tesaro"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Understanding Tesaro’s Gross Margin Trend",
                "features": {
                    "keywords": [
                        "Tesaro",
                        "Gross Margin Trend"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Today's Research Reports on Trending Tickers: Altimmune and Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Altimmune",
                        "Johnson & Johnson",
                        "Research Reports"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}